Rydex

Manufacturer
Centurion Labs
Effective date
2010-06-11
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:24:53

Label at a glance#

ProductRydex
Active ingredientBrompheniramine Maleate, Codeine Phosphate, Pseudoephedrine Hydrochloride
Label structure8 sections

Indications and uses

temporarily relieves these symptoms due to the common cold, hay fever or other upper respiratory allergies (allergic rhinitis): cough due to minor throat and bronchial irritation nasal congestion reduces swelling of the nasal passages runny nose sneezing itching of the nose or throat itchy, water eyes

Dosage and administration

Do not exceed recommended dosage. Adults and children 12 years of age and over: 3 teaspoonfuls (15 mL) every 4 to 6 hours,  not to exceed 18 teaspoonfuls in a 24 hour period. Children 6 to under 12 years of age: 1 1/2 teaspoonfuls (7.5 mL) every 4 to 6 hours, not to exceed 9 teaspoonfuls in a 24 hour period. Not recommended for children under 6 years of age.

Storage and handling

Each 5 mL (one teaspoonful) contains:  sodium 2 mg Store at 59° - 86°F (15° - 30°C)

Label contents#

Full prescribing information#

Drug Facts

OTC - PURPOSE SECTION

Active ingredients                                                          Purpose
(in each 5 mL teaspoonful)

Brompheniramine Maleate 1.33 mg..................................................Antihistamine
Codeine Phosphate*6.33 mg............................................................Antitussive
                                                                                           (Cough Suppressant)
*WARNING:  May be habit forming
Pseudoephedrine Hydrochloride 10 mg.............................................Nasal Decongestant

Uses

INDICATIONS & USAGE SECTION

temporarily relieves these symptoms due to the common cold, hay fever or other upper respiratory allergies (allergic rhinitis):

  • cough due to minor throat and bronchial irritation
  • nasal congestion
  • reduces swelling of the nasal passages
  • runny nose
  • sneezing
  • itching of the nose or throat
  • itchy, water eyes

Warnings

WARNINGS SECTION

Do not exceed recommended dosage.

Do not use this product

OTC - DO NOT USE SECTION

  • if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug.  If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.

Ask a doctor before use if you have

OTC - ASK DOCTOR SECTION

  • a cough that lasts or is chronic such as occurs with smoking, asthma or emphysema
  • a cough that occurs with too much phlegm (mucus)
  • chronic pulmonary disease or shortness of breath, or children who are taking other drugs
  • heart disease
  • high blood pressure
  • thyroid disease
  • a breathing problem such as emphysema or chronic bronchitis
  • trouble urinating due to an enlarged prostate gland

Ask a doctor or pharmacist before use if you are

OTC - ASK DOCTOR/PHARMACIST SECTION

taking sedatives or tranquilizers.

When using this product

OTC - WHEN USING SECTION

  • excitability may occur, especially in children
  • may cause marked drowsiness
  • avoid alcoholic drinks
  • alcohol, sedatives, and tranquilizers may increase drowsiness
  • be careful when driving a motor vehicle or operating machinery

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • nervousness, dizziness, or sleeplessness occur
  • cough or nasal congestion persists for more than 1 week, tends to recur, or is accompanied by a fever, rash or persistent headache.  These could be signs of a serious condition.
  • may cause or aggravate constipation

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

Do not exceed recommended dosage.


Adults and children 12 years of age
and over:
3 teaspoonfuls (15 mL) every 4 to 6 hours,
 not to exceed 18 teaspoonfuls in a 24 hour period.
Children 6 to under 12 years of age:
1 1/2 teaspoonfuls (7.5 mL) every 4 to 6 hours,
not to exceed 9 teaspoonfuls in a 24 hour period.
Not recommended for children under 6 years of age.


Other information

STORAGE AND HANDLING SECTION

Each 5 mL (one teaspoonful) contains:  sodium 2 mg
Store at 59° - 86°F (15° - 30°C)

Inactive ingredients

INACTIVE INGREDIENT SECTION

Citric Acid, Cotton Candy Flavor, FD and C Red #40, Glycerin, Propylene Glycol, Purified Water, Sodium Citrate, Sodium Saccharin, and Sorbitol.

Questions? Comments?

OTC - QUESTIONS SECTION

Call 1-866-959-4880
Mon. - Fri. (8am - 5pm) CST.
Call your doctor for medical advise about side effects.  Serious side effects associated with this product may be reported to this number.

Product Packaging:

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Packaging below represents the labeling currently used:

Principal display panel and side panel for 473 mL label:

NDC 23359-023-16

Rydex Liquid

Antihistamine/Antitussive/Nasal Decongestant

Sugar Free/Alcohol Free

Each 5mL (ONE TEASPOONFUL) FOR ORAL ADMINISTRATION CONTAINS:

Brompheniramine Maleate..............................1.33 mg
Codeine Phosphate........................................6.33 mg
(WARNING:  May be habit-forming.)
Pseudoephedrine Hydrochloride.........................10 mg

CV

Cotton Candy Flavor

Centurion Labs, LLC
Leading Pharmaceuticals

16 fl. oz. (473 mL)

Tamper evident by foil seal under cap.  Do not use if foil seal is broken or missing.

Dispense in a tight, light-resistant container, as defined in the USP/NF, with a child resistant cap.

This package not intended for dispensing to the patient.

Store at 59° - 86°F(15° - 30°C)

Manufactured for:
Centurion Labs, LLC
Birmingham, AL 35243

Rev. 04/10


Rydex Packaging
Rydex Packaging



Rydex Packaging
Rydex Packaging









DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
994289codeine phosphate 6.33 MG / brompheniramine maleate 1.33 MG / pseudoephedrine HCl 10 MG in 5 mL Oral SolutionPSN1
994289brompheniramine maleate 0.27 MG/ML / codeine phosphate 1.27 MG/ML / pseudoephedrine hydrochloride 2 MG/ML Oral SolutionSCD1
994289brompheniramine maleate 1.33 MG / codeine phosphate 6.33 MG / pseudoephedrine hydrochloride 10 MG per 5 ML Oral SolutionSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
PSEUDOEPHEDRINE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
41b814f3-0166-1c53-c9ef-a0794c7daf9dProduct name320221110
a590be26-846c-8659-a5a1-fb25907965dcProduct name220221110
09d8330d-4fec-be98-3a66-f985140646b2Product name220210513
ba088a92-ab5e-b2d4-e908-f5ea691b7587Product name720210201
20c8cafe-5cfc-44f8-a9be-a664f437f780Product name220200225
0fdb98e2-b951-a1ce-5715-2b187ba500efProduct name420170718
e974e22d-8688-7d92-1e87-40c1079e170cProduct name320151125
182f9ab4-4ab5-c449-200f-87ce2ce8e550Product name220151105
e0b6c8be-f2bd-9f86-a9fc-3ed56ffaa814Product name320150910
c0200ab5-4954-454e-9676-30b741b245bdProduct name120150730
e8718272-64cb-4436-969b-176c3067c8f4Product name120150609
2a21311a-89e2-0e83-2ebd-117f9798b2b2Product name120140508
30c51294-7ae9-8007-7de6-58222684a0beProduct name120140508
47fd879b-91c5-e1e5-130f-29d082a871ecProduct name120140508
4f26f669-fc6c-40ef-9e26-1c7b2390ee66Product name120140508
70a83adc-6047-bbea-5a08-dfd304aa47d2Product name120140508
858ce051-9941-aafc-8c7c-44a8e0227463Product name120140508
b893258d-0942-3d8a-3411-056ea0788ff5Product name120140508
c35d1ac8-8885-2ee1-6c52-5a715b242c00Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
23359-023-162019-10-21C16284748780-1956f9ecf-bc1c-621f-e053-dbdaa90a74adRydex Liquid

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
23359-023-16Rydex473 mL in 1 BOTTLELIQUID4731

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
23359-023RYDEX (BROMPHENIRAMINE MALEATE, CODEINE PHOSPHATE, PSEUDOEPHEDRINE HYDROCHLORIDE) LIQUID [CENTURION LABS]1Legacy NDC, 1 package rows20100621_9751b120-49d4-46dd-82cc-638412b5f86d.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
23359-023-16ML - Milliliter23359-023b8022053-d0e0-4ab3-b05f-e3276ffb4b2b12012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
Brompheniramine MaleateACTIVE INGREDIENTIXA7C9ZN031
Codeine PhosphateACTIVE INGREDIENTGSL05Y1MN61
Pseudoephedrine HydrochlorideACTIVE INGREDIENT6V9V2RYJ8N1
BrompheniramineACTIVE MOIETYH57G17P2FN1
CodeineACTIVE MOIETYQ830PW75201
PseudoephedrineACTIVE MOIETY7CUC9DDI9F1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
23359-02323359-023-16

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 3 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
03a0c43b-b783-44a6-a9ff-ad862fb95a829751b120-49d4-46dd-82cc-638412b5f86d2010-06-11WarningsExact identifier
spl id: 03a0c43b-b783-44a6-a9ff-ad862fb95a82
spl set id: 9751b120-49d4-46dd-82cc-638412b5f86d

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.